First commercial deployment of FDB Script Agent™ with Tebra converts ambient encounter dialogue into structured prescriptions for clinician review, grounded in trusted medication intelligence
Featured News
Medical Devices & Biotechnology News
FDA Approves an Autoinjector Version of LEROCHOL® (lerodalcibep-liga) and Updated Indication
FDA also approved a positive update to the LEROCHOL indication statement reflecting the well-recognized reduction of risk for major adverse cardiovascular events achieved in adults via LDL-C lowering when treated with statins or with monoclonal antibody PCSK9 inhibitors used as an add-on to statin therapy
Guardian Flex is 30% smaller than Medical Guardian's previous-generation wearable, combining advanced sensing, nationwide connectivity, and award-winning 24/7 professional monitoring to deliver our most seamless and proactive approach to personal health and safety
HearingLife Introduces Oticon Reveal, the World’s First Dual AI-Powered Hearing Aid
Designed to help people with hearing loss experience more natural and effortless listening
Caris Precision Oncology Alliance Welcomes the University of New Mexico Comprehensive Cancer Center
Partnership expands collaborative research network dedicated to advancing precision medicine and improving outcomes for cancer patients
The marketing authorization is valid in all 27 European Union (“EU”) Member States, as well as Iceland, Liechtenstein and Norway. Pfizer and BioNTech have already initiated manufacturing of the monovalent XFG-adapted COVID-19 vaccine at risk to ensure supply readiness in anticipation of the respiratory disease season, when the demand for COVID-19 vaccination is expected to increase.
Clinical Trials | Funding | Mergers & Acquisitions | Market Reports
AbbVie to Present New Data at WCLC 2026 Showcasing Innovation Across Lung Cancer Pipeline
Clinical data from AbbVie's ABBV-1480 (RC148) PD-1/VEGF bispecific antibody in the frontline non-small cell lung cancer (NSCLC) setting will be presented via an oral presentation
P&F Products & Features GmbH Announces Acquisition of AVVie GmbH
The acquisition strengthens P&F's structural heart portfolio with the addition of the AngelValve™ Augmentation System, a novel transcatheter solution for mitral regurgitation, further expanding the company's portfolio of next-generation transcatheter heart valve therapies and reinforcing its long-term commitment to structural heart innovation
The work, led by Roswell Park’s Katerina Gurova, PhD, and Sethera CEO Karsten Eastman, PhD, could open a path toward targeted options for patients with aggressive tumors that have limited treatment choices
Exclusive Report by MarketsandMarkets™
Executives On the Move
Industry Expert Bylines
August 24, 2026
Hospitals
Imaging
Association News
Delray Medical Center and vascular surgeon, Dr. Joseph Ricotta, are the first hospital and physician in South Florida to use the SEISMIQ™ Intravascular Lithotripsy (IVL)
New Agreement Ensures Continued Access to Cedars-Sinai's Nationally Recognized Care, While Advancing Shared Goals for Quality, Patient Experience and Affordability
Olympus Announces Global Distribution Agreement with Endocision for Respiratory Cryobiopsy System
Portable Device is Designed to Support a Variety of Clinical Needs
John Elkann, CEO of Exor, said: "We support Philips’ long-term strategy defined by innovation, value creation and disciplined execution. The updated agreement reflects our continued commitment to Philips as its largest shareholder."
The American Foundation for Suicide Prevention (AFSP) applauds Congress for passing the bipartisan Youth Poisoning Protection Act, marking a significant milestone in a years-long effort to prevent suicide by reducing access to a highly lethal means
Participation in the FasterCures TRAIN network strengthens DDF's ability to connect researchers with the resources and relationships that accelerate stomach cancer research.
